Intrinsic Vascularization of Recombinant eADF4(C16) Spider Silk Matrices in the Arteriovenous Loop Model
Publication: Tissue Engineering Part A
Volume 25, Issue Number 21-22
Abstract
The surgically induced angiogenesis by means of arteriovenous (AV) loops represents a powerful method to significantly enhance vascularization of biomaterials. Regarding tissue engineering applications, spider silk is a promising biomaterial with a good biocompatibility and slow biodegradation. This study aims at investigating vascularization as well as de novo tissue formation of fibrous matrices made of electro-spun (ES) or wet-spun (WS) engineered ADF4(C16) spider silks in the rat AV loop model. Either ES or WS spider silk fibrous matrices were filled into Teflon chambers. Intrinsic vascularization was induced by means of an AV loop. After 4 weeks of vascularization, de novo tissue formation and biocompatibility were analyzed. Regardless of their significantly differing fiber diameters, both ES and WS eADF4(C16) fiber matrices displayed a good biocompatibility and initiated de novo tissue formation as well as vessel formation. Both matrices demonstrated partial vascularization originating from the AV loop, with more vessels in spider silk matrices with lower fiber diameters. We were able to demonstrate intrinsic vascularization of spider silk fibrous matrices by means of the AV loop. Moreover, our study indicates that the adjustment of the fiber diameter of engineered spider silks enables new possibilities to optimize vascularization.
Impact Statement
Spider silk is a promising biomaterial demonstrating excellent biocompatibility and biodegradation. Biotechnology allows the high-volume production of recombinant spider silk proteins, such as eADF4(C16), with the required purity for biomedical applications. In this study, eADF4(C16) fibrous matrices were produced by either electro- or wet-spinning, resulting in different fiber diameters. Forming an arteriovenous fistula, surgical vascularization of the scaffolds was induced. After 4 weeks, both silks demonstrated a good biocompatibility and tissue formation. The thinner electro-spun fibers displayed a faster biodegradation and vascularization, indicating that the adjustment of the fiber diameter is a valuable tool to fine-tune vascularization and biodegradation.
Get full access to this article
View all available purchase options and get full access to this article.
References
1. Koob S., Torio-Padron N., Stark G.B., Hannig C., Stankovic Z., and Finkenzeller G. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng Part A 17, 311, 2011.
2. Strassburg S., Nienhueser H., Bjorn Stark G., Finkenzeller G., and Torio-Padron N. Co-culture of adipose-derived stem cells and endothelial cells in fibrin induces angiogenesis and vasculogenesis in a chorioallantoic membrane model. J Tissue Eng Regen Med 10, 496, 2016.
3. Arkudas A., Pryymachuk G., Hoereth T., et al. Dose-finding study of fibrin gel-immobilized vascular endothelial growth factor 165 and basic fibroblast growth factor in the arteriovenous loop rat model. Tissue Eng Part A 15, 2501, 2009.
4. Erol O.O., and Sira M. New capillary bed formation with a surgically constructed arteriovenous fistula. Plast Reconstr Surg 66, 109, 1980.
5. Pribaz J.J., Maitz P.K., and Fine N.A. Flap prefabrication using the “vascular crane” principle: an experimental study and clinical application. Br J Plast Surg 47, 250, 1994.
6. Polykandriotis E., Tjiawi J., Euler S., et al. The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res 75, 25, 2008.
7. Rath S.N., Arkudas A., Lam C.X., et al. Development of a pre-vascularized 3D scaffold-hydrogel composite graft using an arterio-venous loop for tissue engineering applications. J Biomater Appl 27, 277, 2012.
8. Arkudas A., Balzer A., Buehrer G., et al. Evaluation of angiogenesis of bioactive glass in the arteriovenous loop model. Tissue Eng Part C Methods 19, 479, 2013.
9. Buehrer G., Balzer A., Arnold I., et al. Combination of BMP2 and MSCs significantly increases bone formation in the rat arterio-venous loop model. Tissue Eng Part A 21, 96, 2015.
10. Arkudas A., Beier J.P., Heidner K., et al. Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. Tissue Eng 13, 1549, 2007.
11. Arkudas A., Beier J.P., Pryymachuk G., et al. Automatic quantitative micro-computed tomography evaluation of angiogenesis in an axially vascularized tissue-engineered bone construct. Tissue Eng Part C Methods 16, 1503, 2010.
12. Guan X., Avci-Adali M., Alarcin E., et al. Development of hydrogels for regenerative engineering. Biotechnol J 12, [Epub ahead of print];, 2017.
13. Yu Q., Xu S., Zhang H., Gu L., Xu Y., and Ko F. Structure-property relationship of regenerated spider silk protein nano/microfibrous scaffold fabricated by electrospinning. J Biomed Mater Res A 102, 3828, 2014.
14. Meinel L., Hofmann S., Karageorgiou V., et al. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26, 147, 2005.
15. Jao D., Mou X., and Hu X. Tissue regeneration: a silk road. J Funct Biomater 7, pii:, 2016.
16. Muller-Herrmann S., and Scheibel T. Enzymatic degradation of films, particles, and nonwoven meshes made of a recombinant spider silk protein. ACS Biomater Sci Eng 1, 247, 2015.
17. Schacht K., Vogt J., and Scheibel T. Foams made of engineered recombinant spider silk proteins as 3D scaffolds for cell growth. ACS Biomater Sci Eng 2, 517, 2016.
18. Doblhofer E., Heidebrecht A., and Scheibel T. To spin or not to spin: spider silk fibers and more. Appl Microbiol Biotechnol 99, 9361, 2015.
19. Lang G., Neugirg B.R., Kluge D., Fery A., and Scheibel T. Mechanical testing of engineered spider silk filaments provides insights into molecular features on a mesoscale. ACS Appl Mater Inter 9, 892, 2017.
20. Leal-Egana A., Lang G., Mauerer C., et al. Interactions of fibroblasts with different morphologies made of an engineered spider silk protein. Adv Eng Mater 14, B67, 2012.
21. Helfricht N., Doblhofer E., Duval J.F.L., Scheibel T., and Papastavrou G. Colloidal properties of recombinant spider silk protein particles. J Phys Chem C 120, 18015, 2016.
22. Wohlrab S., Muller S., Schmidt A., et al. Cell adhesion and proliferation on RGD-modified recombinant spider silk proteins. Biomaterials 33, 6650, 2012.
23. DeSimone E., Schacht K., Pellert A., and Scheibel T. Recombinant spider silk-based bioinks. Biofabrication 9, 044104, 2017.
24. Schacht K., Jungst T., Schweinlin M., Ewald A., Groll J., and Scheibel T. Biofabrication of cell-loaded 3D spider silk constructs. Angew Chem Int Ed Engl 54, 2816, 2015.
25. Zeplin P.H., Maksimovikj N.C., Jordan M.C., et al. Spider silk coatings as a bioshield to reduce periprosthetic fibrous capsule formation. Adv Funct Mater 24, 2658, 2014.
26. Huemmerich D., Scheibel T., Vollrath F., Cohen S., Gat U., and Ittah S. Novel assembly properties of recombinant spider dragline silk proteins. Curr Biol 14, 2070, 2004.
27. Vendrely C., and Scheibel T. Biotechnological production of spider-silk proteins enables new applications. Macromol Biosci 7, 401, 2007.
28. Kneser U., Polykandriotis E., Ohnolz J., et al. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng 12, 1721, 2006.
29. Klumpp D., Rudisile M., Kuhnle R.I., et al. Three-dimensional vascularization of electrospun PCL/collagen-blend nanofibrous scaffolds in vivo. J Biomed Mater Res A 100, 2302, 2012.
30. Weis C., Covi J.M., Hilgert J.G., et al. Automatic quantification of angiogenesis in 2D sections: a precise and timesaving approach. J Microsc 259, 185, 2015.
31. Rath S.N., Pryymachuk G., Bleiziffer O.A., et al. Hyaluronan-based heparin-incorporated hydrogels for generation of axially vascularized bioartificial bone tissues: in vitro and in vivo evaluation in a PLDLLA-TCP-PCL-composite system. J Mater Sci Mater Med 22, 1279, 2011.
32. Enomoto S., Sumi M., Kajimoto K., et al. Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material. J Vasc Surg 51, 155, 2010.
33. Zhang J., Huang H., Ju R., et al. In vivo biocompatibility and hemocompatibility of a polytetrafluoroethylene small diameter vascular graft modified with sulfonated silk fibroin. Am J Surg 213, 87, 2017.
34. Lovett M., Eng G., Kluge J.A., Cannizzaro C., Vunjak-Novakovic G., and Kaplan D.L. Tubular silk scaffolds for small diameter vascular grafts. Organogenesis 6, 217, 2010.
35. Han H., Ning H., Liu S., et al. Silk biomaterials with vascularization capacity. Adv Funct Mater 26, 421, 2016.
36. Stoppato M., Stevens H.Y., Carletti E., Migliaresi C., Motta A., and Guldberg R.E. Effects of silk fibroin fiber incorporation on mechanical properties, endothelial cell colonization and vascularization of PDLLA scaffolds. Biomaterials 34, 4573, 2013.
37. Zeplin P.H., Berninger A.K., Maksimovikj N.C., van Gelder P., Scheibel T., and Walles H. [Improving the biocompatibility of silicone implants using spider silk coatings: immunohistochemical analysis of capsule formation]. Handchir Mikrochir Plast Chir 46, 336, 2014 (Article in German).
38. Arkudas A., Tjiawi J., Bleiziffer O., et al. Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model. Mol Med 13, 480, 2007.
39. Ghanaati S., Unger R.E., Webber M.J., et al. Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells. Biomaterials 32, 8150, 2011.
40. Unger R.E., Ghanaati S., Orth C., et al. The rapid anastomosis between prevascularized networks on silk fibroin scaffolds generated in vitro with cocultures of human microvascular endothelial and osteoblast cells and the host vasculature. Biomaterials 31, 6959, 2010.
41. Fuchs S., Motta A., Migliaresi C., and Kirkpatrick C.J. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials 27, 5399, 2006.
42. Zhang W., Zhu C., Wu Y., et al. VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur Cells Mater 27, 1, 2014.
43. Arkudas A., Pryymachuk G., Beier J.P., et al. Combination of extrinsic and intrinsic pathways significantly accelerates axial vascularization of bioartificial tissues. Plast Reconstr Surg 129, 55e, 2012.
Information & Authors
Information
Published In

Tissue Engineering Part A
Volume 25 • Issue Number 21-22 • November 2019
Pages: 1504 - 1513
PubMed: 30848159
Copyright
Copyright 2019, Mary Ann Liebert, Inc., publishers.
History
Published online: 6 November 2019
Published in print: November 2019
Published ahead of print: 2 May 2019
Published ahead of production: 8 March 2019
Accepted: 25 February 2019
Received: 14 December 2018
Authors
Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.